NSI-189 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "NSI-189" in Italian language version.

refsWebsite

Global rank Italian rank

2^nd place

7^th place

4^th place

9^th place

2web.archive.org

1^st place

1^st place

2neuralstem.com

low place

low place

234^th place

226^th place

1clinicaltrials.gov

5,225^th place

5,296^th place

9,716^th place

535^th place

1globenewswire.com

2,614^th place

4,188^th place

6^th place

8^th place

archive.org

ia801600.us.archive.org

Corporate presentation neuralstem (PDF), marzo 2016.

clinicaltrials.gov

(EN) Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects - Full Text View - ClinicalTrials.gov, su clinicaltrials.gov. URL consultato il 27 maggio 2017.

doi.org

dx.doi.org

(EN) M. Fava, K. Johe e L. Ereshefsky, A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients, in Molecular Psychiatry, vol. 21, n. 10, 1º ottobre 2016, pp. 1372–1380, DOI:10.1038/mp.2015.178. URL consultato il 27 maggio 2017.
Naoki Tajiri, David M. Quach e Yuji Kaneko, NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats, in Journal of Cellular Physiology, 9 febbraio 2017, DOI:10.1002/jcp.25847. URL consultato il 27 maggio 2017.
Roger S. McIntyre, Karl Johe e Carola Rong, The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects, in Expert Opinion on Investigational Drugs, vol. 26, n. 6, 1º giugno 2017, pp. 767–770, DOI:10.1080/13543784.2017.1324847. URL consultato il 27 maggio 2017.

globenewswire.com

(EN) Neuralstem, Inc., Neuralstem Awarded $~1MM Grant by NIH to Continue Preclinical Research into the Potential of NSI-189 for Treatment of Diabetic Neuropathy, in GlobeNewswire News Room. URL consultato il 31 agosto 2017.

nature.com

(EN) M. Fava, K. Johe e L. Ereshefsky, A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients, in Molecular Psychiatry, vol. 21, n. 10, 1º ottobre 2016, pp. 1372–1380, DOI:10.1038/mp.2015.178. URL consultato il 27 maggio 2017.

neuralstem.com

investor.neuralstem.com

FDA approves Neuralsteam to treat final cohort in NSI-189 ^{[collegamento interrotto]}, in Neuralstem, Inc..

neuralstem.com

(EN) Neuralstem, Inc. (CUR), su Neuralstem, Inc.. URL consultato il 31 agosto 2017.

nih.gov

ncbi.nlm.nih.gov

Thomas Frodl, Annette Schaub e Sandra Banac, Reduced hippocampal volume correlates with executive dysfunctioning in major depression, in Journal of Psychiatry and Neuroscience, vol. 31, n. 5, 27 maggio 2017, pp. 316–325. URL consultato il 27 maggio 2017.
Naoki Tajiri, David M. Quach e Yuji Kaneko, NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats, in Journal of Cellular Physiology, 9 febbraio 2017, DOI:10.1002/jcp.25847. URL consultato il 27 maggio 2017.
Roger S. McIntyre, Karl Johe e Carola Rong, The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects, in Expert Opinion on Investigational Drugs, vol. 26, n. 6, 1º giugno 2017, pp. 767–770, DOI:10.1080/13543784.2017.1324847. URL consultato il 27 maggio 2017.

unipd.it

UNIPD, Una nuova molecola contro la depressione, su unipd.it. URL consultato il 27 maggio 2017.

web.archive.org

(EN) NSI-189: A Nootropic Antidepressant That Promotes Neurogenesis, in Nootropix.com, 1º maggio 2017. URL consultato il 27 maggio 2017 (archiviato dall'url originale il 20 maggio 2016).
(EN) Administrator, Major Depression, su neuralstem.com. URL consultato il 27 maggio 2017 (archiviato dall'url originale il 26 maggio 2017).